NCT00277706View on ClinicalTrials.gov

Impact of Parathyroid Hormone (PTH) on Osseous Cavity

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
Bone LossPeriodontitis
Interventions
PROCEDURE

Periodontal surgery

DRUG

FORTEO

parathyroid hormone; self-administration for 6 weeks

DRUG

Placebo

placebo; self administration for 6 weeks

DIETARY_SUPPLEMENT

Vitamin D and Calcium

PO, QD, for six weeks

Trial Locations (1)

48106

Michigan Center for Oral Health Research, Ann Arbor

All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

University of Michigan

OTHER

NCT00277706 - Impact of Parathyroid Hormone (PTH) on Osseous Cavity | Biotech Hunter | Biotech Hunter